New migraine drug shows promise in early trial
NCT ID NCT06728553
Summary
This study tested if a new under-the-tongue medication called MTX101 could safely and effectively treat migraine pain when it starts. 78 adults with a history of migraines took either the drug or a placebo pill for two separate migraine attacks. Researchers compared the results to see if MTX101 reduced pain better than the placebo and checked for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brainstorm Research
Miami, Florida, 33176, United States
-
Clinical Research Institute, LLC
Santa Monica, California, 90048, United States
-
DelRicht Research
New Orleans, Louisiana, 70115, United States
-
Kaizen Brain Center
La Jolla, California, 92037, United States
-
QUEST Research Institute
Farmington Hills, Michigan, 48334, United States
-
Synergy Clinical Research/Emerald Coast Center for Neurological Disorders
Pensacola, Florida, 32504, United States
-
Wasatch Clinical Research
Salt Lake City, Utah, 84107, United States
Conditions
Explore the condition pages connected to this study.